How Are Market Dynamics And Regional Growth Patterns Influencing The Metagenomics In Healthcare Market?

 

What Major Growth Indicators And Market Expansion Forecasts Define The Metagenomics In Healthcare Market Through 2030?
 The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.44 billion in 2025 to $2.87 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to advancements in sequencing technologies, increased incidence of infectious diseases, expansion of microbiome research programs, rising demand for culture-independent diagnostics, availability of clinical-grade sequencing workflows.
 
 The metagenomics in healthcare market size is expected to see rapid growth in the next few years. It will grow to $5.46 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to increasing adoption of precision infectious disease diagnostics, rising investments in microbiome therapeutics, expansion of genomic epidemiology initiatives, growing integration of ai in microbial analysis, increasing focus on personalized treatment strategies. Major trends in the forecast period include increasing adoption of metagenomic diagnostics in clinical settings, growing use of microbiome-based disease profiling, rising integration of ngs in infection management, expansion of personalized microbial therapeutics research, enhanced focus on rapid pathogen identification.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp
 
 Which Drivers Are Playing A Pivotal Role In Shaping The Metagenomics In Healthcare Market’s Growth Outlook?
 The increasing prevalence of infectious diseases is expected to propel the growth of metagenomics in healthcare market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The rising prevalence of infectious diseases is due to increased travel, which facilitates the rapid spread of pathogens across borders. Metagenomics in healthcare helps combat infectious diseases by enabling rapid and precise identification of pathogens, making it crucial for controlling infectious outbreaks. It reduces diagnostic uncertainty by analyzing complex microbial communities, improving patient outcomes, and guiding targeted treatments. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the metagenomics in healthcare market.
 
 How Is The Metagenomics In Healthcare Market Broken Down Based On Its Critical Segment Classifications?
 The metagenomics in healthcare market covered in this report is segmented — 
 
 1) By Types: Sample Extraction Kits, Metagenomics Kits
 2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray
 3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing
 4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery
 5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies
 
 Subsegments:
 1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits
 2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits
 
 What Major Trends Are Set To Shape The Metagenomics In Healthcare Market Outlook Through The Forecast Period?
 Major companies operating in the metagenomics in healthcare market are focusing on developing innovative solutions, such as microbial community profiling, to enhance disease diagnostics, enable personalized therapies, and advance precision medicine. Microbial community profiling refers to the comprehensive analysis and characterization of diverse microbial populations within a specific environment or sample, using sequencing and bioinformatics tools to identify their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a China-based biotechnology company, launched a Human Microbiome Metagenomics Sequencing Package to advance microbial research and healthcare applications. It delivers an automated, end-to-end microbial community profiling workflow for efficiently analyzing human microbiome diversity, function, and disease links using validated high-throughput platforms. It minimizes manual labor, enhances reproducibility, and reduces costs, making large-scale and clinical microbiome research more accessible. The researchers gain advantages from fast and precise microbial identification, along with adaptable throughput, facilitating biomarker discovery and advancing translational health research.
 
 Which Firms Hold A Significant Competitive Position In The Metagenomics In Healthcare Market?
 Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., Wobble Genomics Inc. 
 
 Get Your In-Depth Metagenomics In Healthcare Market Report Now:
 https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report
 
 Which Locations Are Showing Rapid Adoption And Strong Growth Indicators In The Metagenomics In Healthcare Market?
 North America was the largest region in the metagenomics in healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company